Pfizer’s Lyrica (pregabalin) became the first treatment specifically approved for fibromyalgia. Currently, physicians use antidepressants, muscle relaxants and other drugs off-label to ease the symptoms.
Fibromyalgia is a hard-to-define condition with chronic fatigue and extreme pain, usually in women.
Lyrica had been previously approved by the FDA for the treatment of seizures, diabetic nerve pain and nerve pain after shingles.
This is a bit of good news for Pfizer in an otherwise bleak week. On Wednesday, Pfizer learned the FDA had issued an approvable letter for maraviroc, for patients with HIV. The company had expected approval, but still needs to resolve labeling with the agency.
Also on Wednesday, Pfizer discontinued trials for PF-3512676 for the treatment of advanced non-small cell lung cancer. The drug, used in conjunction with cytotoxic chemotherapy, failed to produce any benefit compared to chemotherapy alone. The drug had been licensed from Coley Pharmaceutical Group.